Neumora Therapeutics, Inc. (NMRA)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 7400
-0.01
-0.57%
$
344.63M Market Cap
- P/E Ratio
- Div Yield
647,339 Volume
-1.75 Eps
$ 1.75
Previous Close Want to track NMRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neumora Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 602,403 | $1.08M | $1.05M | -$30,120.21 | -2.79% |
 SkyOak Wealth SkyOak Wealth LLC | 150,000 | $97,573.33 | $261,000 | $163,426.67 | 167.49% |
| AA Andrew Alkon EntryPoint Capital, LLC | 110,875 | $198,466.14 | $192,922.5 | -$5,543.64 | -2.79% |
| AHI Addis & Hill Inc. Addis & Hill, Inc | 163,386 | $2.25M | $284,291.64 | -$1.96M | -87.34% |
| VT Vincent Tortorella Point72 (DIFC) Ltd | 51 | $37.42 | $88.74 | $51.32 | 137.16% |
| KSS Khalifa Sultan Sultan Hazim Lunate Capital Ltd. | 2.12M | $2.12M | $3.7M | $1.57M | 74% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 3,737 | $30,962.67 | $6,502.38 | -$24,460.29 | -79% |
| JB Justin Boggs Optima Capital LLC | 270 | $483 | $469.8 | -$13.2 | -2.73% |
